Overview

CKD-828 (80/5mg) Pharmacokinetic Study

Status:
Completed

Trial end date:
2014-12-01

Target enrollment:

Participant gender:

Summary

A randomized, open-label, single-dose, two-period, two-way, crossover study to compare the pharmacokinetics and safety CKD-828 (Fixed Dose Combination Tablet) to coadministration telmisartan and s-amlodipine in health volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

Chong Kun Dang Pharmaceutical

Treatments:

Amlodipine
Telmisartan